Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
iSERA Lifesciences Limited (formerly Covid Technologies Limited) has informed BSE that a Board meeting is scheduled for April 20, 2026. The meeting will consider and approve a preferential issue of equity shares on a private placement basis along with other business matters. The company has undergone a name change from Covid Technologies Limited to iSERA Lifesciences Limited. The filing is made pursuant to Regulation 29(1)(d) of SEBI (LODR) Regulations, 2015, which requires listed companies to give advance notice of board meetings that may consider matters like preferential issues.
Shareholders should note that a preferential private placement of equity shares will result in dilution of existing shareholding. The stock may see increased volatility around the meeting date and upon announcement of the issue terms.